How COVID-19 Affected the Introduction of Telemedicine and Patient Reported Outcomes Among Patients With Pulmonary Hypertension　― A Report From a Referral Center in Japan ―

Yuichi Tamura; Rika Takeyasu; Asuka Furukawa; Hiromi Takada; Mineki Takechi; Hirohisa Taniguchi; Akio Kawamura

doi:10.1253/circrep.CR-20-0088

This article has now been updated. Please use the final version.

How COVID-19 Affected the Introduction of Telemedicine and Patient Reported Outcomes Among Patients With Pulmonary Hypertension　― A Report From a Referral Center in Japan ―

Yuichi Tamura, Rika Takeyasu, Asuka Furukawa, Hiromi Takada, Mineki Takechi, Hirohisa Taniguchi, Akio Kawamura

Author information

Yuichi Tamura
Pulmonary Hypertension Center, International University of Health and Welfare Mita Hospital [Japan]
Department of Cardiology, International University of Health and Welfare School of Medicine [Japan]
Rika Takeyasu
Pulmonary Hypertension Center, International University of Health and Welfare Mita Hospital [Japan]
Asuka Furukawa
Pulmonary Hypertension Center, International University of Health and Welfare Mita Hospital [Japan]
Department of Cardiology, International University of Health and Welfare School of Medicine [Japan]
Hiromi Takada
Pulmonary Hypertension Center, International University of Health and Welfare Mita Hospital [Japan]
Mineki Takechi
Pulmonary Hypertension Center, International University of Health and Welfare Mita Hospital [Japan]
Hirohisa Taniguchi
Department of Cardiology, International University of Health and Welfare School of Medicine [Japan]
Akio Kawamura
Department of Cardiology, International University of Health and Welfare School of Medicine [Japan]

Keywords: COVID-19, emPHasis-10, Patient-reported outcome, Pulmonary hypertension, Telemedicine

JOURNAL OPEN ACCESS FULL-TEXT HTML Advance online publication
Supplementary material

Article ID: CR-20-0088

DOI https://doi.org/10.1253/circrep.CR-20-0088

The final version of this article is now available: Vol. 2 (2020), No. 9 pp. 526-530

Details

Abstract

Background:COVID-19 is fatal to patients with pulmonary hypertension (PH), so preventive actions are recommended. This study investigated the effectiveness of telemedicine and effects on quality of life (QOL) in the treatment of patients with PH.

Methods and Results:Japanese patients with PH (n=40) were recruited from one referral center. Patient self-reported anxiety worsened significantly and elderly patients in particular experienced detrimental lifestyle changes under COVID-19. Telemedicine worked well to decrease the frequency of going out.

Conclusions:Telemedicine is effective in reducing travel distances, and frequent remote interventions may be desirable for older, anxious patients.

Corresponding author

Register with J-STAGE for free!